Skip to main content
< Back
Lisbon Addictions 2024 logo
  • About
    • About the conference
    • Organisers & Partners
    • Registration
    • App
    • Podcast
    • Early Career Researchers
    • Call for abstracts
    • Guidelines
    • Latest updates
    • Press room
    • Venue
  • Programme
    • Full programme
    • Programme outline
  • Tracks
  • Speakers
    • All speakers
    • Keynote speakers
  • Side events
  • Subscribe
Previous sessionNext session

Emerging challenges in drug markets: monitoring, measurement & impacts

Room 1.05
In programme
Friday, 25 October, 2024 - 10:50 to 12:20
View presentations

About

This panel focuses on emerging drug markets in Europe and Asia and examines new approaches for monitoring and addressing drug problems.

Chair

Placeholder Image
Carpentier
Chloe
Chief of Research and Knowledge Production Section
UNODC

Type

Short communication session

Tracks

Drug policy: latest developments and new challenges

Keywords

Europe
Opiates
Public health
Harm reduction
Overdose
Prescription drugs
Toxicology and forensic analysis
Policy
Criminal justice/prisons
New psychoactive substances
Markets
Alcohol
Nicotine/tobacco
Behavioural addictions
Treatment
Prevention
Risky behaviours
Drug user's perspectives
Monitoring and evaluation
North America

Presentations

Friday, 25 October

10:50

Short communication

An action plan for synthetic opioids - The Zurich approach

10:50 to 12:20
Room 1.05
Dominique Schori

Short communication

Community attitudes towards sanction and health-based interventions for individuals caught drug-driving in Australia

10:50 to 12:20
Room 1.05
Sara Liu

Short communication

Development of an evidence-based classification framework for psychoactive substances in the illicit drug market

10:50 to 12:20
Room 1.05
Michèle Boileau-Falardeau

Short communication

Gabapentinoids in Ireland (2010-2020): trends in prescribing, law enforcement drug seizures &amp; post-mortem toxicology

10:50 to 12:20
Room 1.05
Gráinne Cousins

Short communication

Increasing availability and production of synthetic cathinones in Europe – a perspective from the EU EWS

10:50 to 12:20
Room 1.05
Gregorio Planchuelo

Short communication

MDMA misinformation: what dealers claim versus the actual MDMA content in ecstasy pills in the netherlands

10:50 to 12:20
Room 1.05
Lavinia Stegemann

Short communication

New research unit provides evidence to address national addictions policy challenges

10:50 to 12:20
Room 1.05
Leonie Brose

Short communication

The emergence of nitazenes on the Irish heroin market: Lessons learned and challenges moving forward

10:50 to 12:20
Room 1.05
Nicki Killeen
Previous sessionView the programmeNext session

Lisbon Addictions, European Conference on Addictive Behaviours and Dependencies.

Quick links

  • Policy & disclaimer
  • Diversity statement
  • Newsletter
  • Twitter
  • Facebook
  • Mail
  • LinkedIn

© 2024 Lisbon Addictions 2024 All rights reserved.

MENU
Back

Lisbon Addictions 2024

  • My profile
  • Notifications
  • My favourites
  • Scan contacts
  • My contacts
  • Settings